3 H]thymidine incorporation, suggesting that L-and T-type Ca 2ϩ channels are involved in smooth muscle cell proliferation in the DA. Third, we found that a novel alternatively spliced variant of the ␣ 1C-isoform was highly expressed in the neointimal cushion of the DA, where proliferating and migrating smooth muscle cells are abundant. The basic channel properties of the spliced variant did not differ from those of the conventional ␣1C-subunit. We conclude that multiple VDCC subunits were identified in the DA, and, in particular, ␣ 1C-and ␣1G-subunits were predominant in the DA. A novel spliced variant of the ␣1C-subunit gene may play a distinct role in neointimal cushion formation in the DA. alternative spliced; development; gene expression; fetal circulation THE DUCTUS ARTERIOSUS (DA) is a fetal arterial connection between the pulmonary artery and the descending aorta. After birth, the DA closes immediately, in accordance with its smooth muscle contraction. An increase in oxygen tension and a dramatic decline in circulating prostaglandins are the most important triggers of DA contraction (5). Generally, vascular smooth muscle contraction is induced by Ca 2ϩ / calmodulin-dependent phosphorylation of the regulatory myosin light chain, which is mediated by an increase in intracellular Ca 2ϩ . Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels (VDCCs) and Ca 2ϩ release from intracellular stores are major sources of this increase (8, 26). Thus VDCCs must play an important role in vascular myogenic reactivity and tone of the DA.
THE DUCTUS ARTERIOSUS (DA) is a fetal arterial connection between the pulmonary artery and the descending aorta. After birth, the DA closes immediately, in accordance with its smooth muscle contraction. An increase in oxygen tension and a dramatic decline in circulating prostaglandins are the most important triggers of DA contraction (5) . Generally, vascular smooth muscle contraction is induced by Ca 2ϩ / calmodulin-dependent phosphorylation of the regulatory myosin light chain, which is mediated by an increase in intracellular Ca 2ϩ . Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels (VDCCs) and Ca 2ϩ release from intracellular stores are major sources of this increase (8, 26) . Thus VDCCs must play an important role in vascular myogenic reactivity and tone of the DA.
VDCCs are classified, according to their distinct electrophysiological and pharmacological properties, into low (Ttype) and high (L-, N-, P-, Q-, and R-type) VDCCs (20, 39) . VDCCs consist of different combinations of ␣ 1 -subunits and auxiliary subunits. The ␣ 1 -subunit forms the ion-conducting pore, the voltage sensor, and the interaction sites for Ca 2ϩ channel blockers and activators (15) . Therefore, ␣ 1 -subunits principally determine the channel character of VDCCs. Ten ␣ 1 -subunit isoforms have been identified. Four ␣ 2␦ -subunit complexes and four ␤-subunits, which modulate the trafficking and the biophysical channel properties of ␣ 1 -subunits (1) , have been identified (3) . Although some studies have investigated the role of VDCCs in the DA (28, 37) , characterization of VDCCs, including the composition of each subunit, the developmental change in their expression, and their physiological roles, remains poorly understood.
In addition to their role in determining contractile state, a growing body of evidence has demonstrated that VDCCs play an important role in regulating differentiation and remodeling of vascular smooth muscle cells (SMCs) (14, 17, 41) . The DA dramatically changes its morphology during development. Intimal cushion formation during development is a characteristic feature of vascular remodeling of the DA (10, 30) . Intimal cushion formation involves many cellular processes, including an increase in SMC migration and proliferation, production of hyaluronic acid under the endothelial layer, and impairment of elastin fiber assembly. The role of VDCCs in vascular remodeling of the DA has not been investigated.
In the present study, we identified multiple VDCC subunits in the DA by semiquantitative and quantitative RT-PCR and immunodetection. In particular, ␣ 1C -and ␣ 1G -subunits were predominant in the DA. Furthermore, we will demonstrate the identification of a novel spliced variant of the ␣ 1C -subunit gene that may play a role in neointimal cushion formation of the DA.
MATERIALS AND METHODS
Animals. All animals were cared for in compliance with the guiding principles of the American Physiological Society. The experiments were approved by the Ethical Committee of Animal Experiments of Yokohama City University School of Medicine.
Maternal vitamin A administration. Maturation of the fetal DA was accelerated by maternal administration of vitamin A, as described previously (25, 42) . Briefly, vitamin A [retinyl palmitate, 33 mg, which is equivalent to 18 mg of retinol (Eisai, Tokyo, Japan)] was diluted in polyoxyethylene castor oil and injected intramuscularly into pregnant Wistar rats daily from day 17 of gestation in a dose of 1 mg (3,000 IU)/kg body wt.
Tissue collection and preparation. For developmental studies, we used pooled tissues obtained from Wistar rat embryos on embryonic days 19 (e19, n ϭ 60) and 21 (e21, n ϭ 90) and from neonates on the day of birth (day 0, n ϭ 60). After excision, tissues were immediately frozen in liquid nitrogen and stored at Ϫ80°C.
Semiquantitative and quantitative RT-PCR. Total RNA was isolated from the tissues using TRIzol, as recommended by the manufacturer (Invitrogen, La Jolla, CA). Genomic DNA was digested by DNase I before RT reaction. After annealing to random hexamer, 2 M total RNA was reverse transcribed to cDNA by SuperScript II RT (Invitrogen). For semiquantitative RT-PCR analyses of VDCC subunits, the primers for PCR amplification were designed on the basis of the rat nucleotide sequences of VDCCs (Table 1) to amplify cDNA between two exons, except ␣ 1S-subunit primers. The PCR cycle consisted of denaturation at 94°C for 30 s, annealing at each temperature for 30 s, and elongation at 72°C for 30 s; 35-40 forty cycles were performed. Amplification products were analyzed by 2% agarose gel electrophoresis and ethidium bromide staining. A fragment of GAPDH was amplified as internal control. For quantitative RT-PCR analysis, sequences for PCR primers are listed in Table 2 . The spliced variant of the ␣ 1C-subunit and nonspliced isoform were detected simultaneously by Ca v1.2 (␣1C)-4 primer. Amplification and detection were performed as described previously (40) . Each template was tested at least three times to confirm the reproducibility of the assays. The abundance of each gene was determined relative to GAPDH using TaqMan rodent GAPDH control reagents kits (Applied Biosystems, Foster City, CA). For each RT-PCR experiment, we included RT negative control and confirmed no amplification in each reaction.
Restriction enzyme analysis. The relative abundance of high-voltage-activated (HVA) channels of the ␣ 1-subunits was determined in the DA as described previously (29) . Briefly, all HVA channels of the ␣ 1-subunits were amplified by RT-PCR using the following set of primers: at(c/t) (a/g)tc acc ttc cag gag ca (forward) and gcg tag atg aag aa(a/g/c) agc at (reverse). Five restriction enzymes selectively cut the ␣ 1A-, ␣1B-, ␣1C-, ␣1D-, and ␣1E-isoforms of the PCR products. The intensity of the digested fragments in correspondence to each isoform was measured by a FujiFilm image analysis system (Image Gauge version 3.41).
Generation of polyclonal antibody against spliced variant of ␣1C-subunit. We generated a polyclonal antibody against spliced variant of rat ␣ 1C-subunit using a keyhole limpet hemocyanin-conjugated synthetic peptide for immunization. Antigens for spliced variant of anti-rat ␣ 1C-subunit antibody were derived from the I-II cytoplasmic loop region spanning amino acids 59 -71 of the spliced variant of rat ␣1C-subunit (RGAPAGLHDQKKGϩC). A male Japanese White rabbit was immunized four times every 2 wk. Serum was collected, and polyclonal antibody was affinity purified.
Immunoblotting. The membrane fraction was prepared and immunoblotting was performed as described previously (23) . Briefly, tissues from rat (DA, aorta, atria, left ventricle, and lung) were homogenized in an ice-cold buffer [in mM: 50 Tris (pH 8.0), 1 EDTA, 1 EGTA, 1 dithiothreitol, and 200 sucrose] and protease inhibitors (Complete Mini, Roche, Tokyo, Japan). The polyclonal antibody specific for ␣ 1C-, ␣1D-, and ␣1G-subunits (Chemicon, Temecula, CA) or spliced variant of ␣1C-subunit at 5 g/ml was used to examine 20-g membrane fractions from rat tissues.
Immunohistochemistry. For immunoperoxidase demonstration of VDCCs in the DA, paraffin-embedded blocks containing DA tissues were cut into 4-m-thick sections and placed on 3-aminopropyltriethoxysilane-coated glass slides. To determine the boundary line of intimal cushion formation, tissue sections were stained with Elastica van Gieson as recommended by the manufacturer (Muto Pure Chemicals). The specimens were deparaffinized, rehydrated, and incubated for 5 min in peroxidase-blocking reagent (DAKO Laboratories) to inactivate endogenous peroxidases. Slides were incubated with each primary antibody of splicing variant of ␣ 1C-, ␣1D-, ␣1G-, and ␣1C-subunits (1:200 dilution) at room temperature for 30 min. After they were washed with 0.1 M PBS for 5 min, the slides were incubated for 30 min in biotinylated rabbit anti-goat IgG (Vector, Burlingame, CA). Then the slides were washed with 0.1 M PBS for 5 min, incubated for 30 min in avidin-biotin-horseradish peroxidase complex (Vector), and washed again with 0.1 M PBS for 5 min. The peroxidase reactivity was demonstrated with 3,3'-diaminobenzidine (Sigma, St. Louis, MO) and 0.3% H 2O2 for 5 min. The specificity of staining was examined by omission of the primary antibodies. The slides were counterstained with Mayer's hematoxylin.
Primary culture of rat DA SMCs. Vascular SMCs in primary culture were obtained from the DA of Wistar rat embryos at e21. The tissues were minced and transferred to a 1.5-ml centrifuge tube that contained 800 l of collagenase-dispase enzyme mixture [1.5 mg/ml collagenase-dispase (Roche), 0.5 mg/ml elastase type II-A (Sigma Immunochemicals, St. Louis, MO), 1 mg/ml trypsin inhibitor type I-S (Sigma), and 2 mg/ml bovine serum albumin fraction V (Sigma) in Hanks' balanced salt solution (Sigma)]. The digestion was carried out at 37°C for 15-20 min. Then cell suspensions were centrifuged, and the medium was changed to the collagenase II enzyme mixture [1 mg/ml collagenase II (Worthington), 0.3 mg/ml trypsin inhibitor type I-S, and 2 mg/ml bovine serum albumin fraction V in Hanks' balanced salt solution]. After 12 min of incubation at 37°C, cell suspensions were transferred to growth medium in 35-mm poly-L-lysine (Sigma)- RT-PCR for L-type Ca 2ϩ channel ␣1-subunit isoforms in rat ductus arteriosus (DA), aorta, skeletal muscle, and retina. RNA samples from tissues were processed for 35 cycles of PCR using primers directed to the cDNA sequence of VDCC ␣1S-, ␣1C-, ␣1D-, and ␣1F-isoforms. PCR of the primer alone, without template, resulted in no product (data not shown). Transcripts for ␣1C-and ␣1D-subunits were detected in DA and aorta, but no transcripts for ␣1S-and ␣1F-subunits were detected in DA and aorta. Transcripts for ␣1C-subunit were detected as clear bands of expected (378 bp) and longer (453 bp) lengths. Sequence analysis detected insertion of an unreported 75-bp cDNA in the 453-bp band into the 378-bp band. Expression of ␣1C-subunit mRNA was not altered during development. Expression of ␣1D-subunit mRNA was decreased in DA from embryonic day 21 (e21) but decreased from day 0 (birth) in aorta. B: RT-PCR for T-type Ca 2ϩ channel ␣1G-, ␣1H-, and ␣1I-subunits in rat DA, aorta, skeletal muscle, and retina. Transcripts for these subunits were present in DA and aorta. Expression level of ␣1G-subunit mRNA was high from embryonic day 19 (e19) to day 0 in DA and aorta and decreased in adult aorta. Levels of ␣1H-and ␣1I-subunit mRNA expression were low in DA and aorta. C: RT-PCR for ␣2␦-subunits in rat DA and aorta during development. Transcripts for all 4 ␣2␦-subunit isoforms were present in both tissues. D: RT-PCR for ␤-subunits in rat DA and aorta during development. Transcripts for 4 ␤-isoforms were present in both tissues. ␤3-Subunit mRNA was abundant in DA and aorta throughout development. coated dishes in a moist tissue culture incubator at 37°C in 5% CO 2-95% ambient mixed air. The growth medium contained DMEM with 10% FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen). The confluent cells were used at passages 4 -6. We confirmed that Ͼ99% of cells were positive for ␣-smooth muscle actin and showed the typical "hill-and-valley" morphology.
Cell proliferation assays. [ 3 H]thymidine incorporation was used to measure cell proliferation in DA SMCs. The SMCs were reseeded into a 24-well culture plate at an initial density of 1 ϫ 10 5 cells per well for 24 h before serum starvation with DMEM containing 0.5% FCS. Cells were then incubated with or without nitrendipine (1 M), kurtoxin (1 M), and efonidipine (3 M) for 16 h in the starvation medium before addition of 1 Ci of [methyl-
3 H]thymidine (specific activity 5 Ci/mM; Amersham International, Bucks, UK) for 4 h at 37°C. After fixation with 1.0 ml of 10% trichloroacetic acid, the cells were solubilized with 0.5 ml of 0.5 M NaOH and then neutralized with 0.25 ml of 1 N HCl. A liquid scintillation counter was used to measure [ 3 H]thymidine incorporation. Data obtained from triplicate wells were averaged.
Generation of expression construct for spliced variant of rat ␣1C-subunit. The 220-bp fragment containing a 75-bp insertion of the spliced variant of rat VDCC ␣1C-subunit was extracted from the 453-bp PCR fragment using Xho I and Sph I restriction enzymes. Then the 220-bp fragment was introduced into the Xho I/Sph I site of the pcDNA3.1(ϩ)-based expression construct of the rat brain 1C subunit (rbCII; kindly supplied by Dr. T. P. Snutch) (35) . The sequence of the expression construct was confirmed by direct sequencing analysis.
Electrophysiological recordings. Ca V1.2 (rbCII; GenBank accession no. M67515) or its mutant was transiently expressed in BHK6 cells, which stably express ␤ 1-and ␣2␦-subunits. Transfection was carried out with a transfection reagent (FuGene 6, Roche), as previously described (43) .
Electrophysiological recordings were performed in the whole cell patch-clamp configuration using a patch/whole cell-clamp amplifier (Axopatch 200B, Axon Instruments) and an analog-to-digital converter (Digidata 1200, Axon Instruments) (43) . Data acquisition was performed with pCLAMP7 software (Axon Instruments). Signals were filtered at 5 kHz. Capacitative currents were electrically compensated. The P/4 protocol (pCLAMP7) was used for leak subtraction. Ca 2ϩ currents and Ba 2ϩ currents (IBa) through CaV1.2 (rbCII) Ca 2ϩ channels expressed in BHK6 cells were measured as previously described (27) . The external solution contained (in mM) 137 NaCl, 5.4 KCl, 1 MgCl 2, 10 HEPES, and 10 glucose, with 2 CaCl2 or BaCl2 as a charge carrier; pH was adjusted to 7.4 with NaOH at room temperature. The resistance of the patch electrode was 2-2.5 M⍀ when it was filled with the pipette solution containing (in mM) 120 CsMeSO 4, 20 TEA-Cl, 14 EGTA, 5 Mg-ATP, 5 Na2 creatine phosphate, 0.2 GTP, and 10 HEPES, with pH adjusted to 7.3 with CsOH at room temperature. All experiments were carried out at room temperature. The half-activation potential (V h-act) was estimated by fitting the current-voltage (I-V) relations (curves) to the following equation by an interactive nonlinear regression fitting procedure
where Vm is membrane potential, Vrev is reversal potential, k is slope factor, and Gmax is maximum conductance.
Half-inactivation voltage (Vh-inact) was estimated by fitting the steady-state inactivation curves to the following equation
where I max and Imin are maximum and minimum plateau currents, respectively, and k is slope factor.
Statistical analysis. Values are means Ϯ SE. Student's unpaired t-tests and unpaired ANOVA followed by the Student-Newman-Keuls test were used for statistical analysis. P Ͻ 0.05 was considered statistically significant.
RESULTS
Multiple transcripts of VDCC ␣ 1 -, ␣ 2␦ -, and ␤-subunits in rat DA. Semiquantitative RT-PCR analyses revealed that, among voltage-dependent L-type Ca 2ϩ channel subunits, ␣ 1C -and ␣ 1D -subunit mRNAs were expressed in the DA and the aorta, whereas neither ␣ 1F -nor ␣ 1S -subunit transcript was detected (Fig. 1A) . The ␣ 1C -subunit transcripts were amplified as two bands, 378 bp (the expected size) and 453 bp, in the RT-PCR products. The 378-bp band was confirmed as the reported VDCC ␣ 1C -subunit, and the 453-bp band was identified as a novel spliced variant of the rat VDCC ␣ 1C -subunit by sequencing analysis. Another spliced variant of ␣ 1C -subunit in the human, which displayed oxygen-sensitive opening of the channel, was recently identified (11) . However, we could not detect this spliced variant in DA, aorta, and genomic DNA in the rat by RT-PCR using Ca v 1.2 (␣ 1C )-2 primers, although we could detect its expression in human right ventricle (data not shown). The expression of VDCC ␣ 1A (P/Q-type)-, ␣ 1B (Ntype)-, and ␣ 1E (R-type)-subunits was not detected in the DA by semiquantitative RT-PCR (data not shown).
The transcripts of all T-type Ca 2ϩ channel ␣ 1 -subunits, ␣ 1G , ␣ 1H , and ␣ 1I , were detected in the DA and aorta (Fig. 1B) . In our PCR conditions, expression of the ␣ 1G -isoform was highest and expression of the ␣ 1H -isoform was lowest in the DA among T-type Ca 2ϩ channel ␣ 1 -subunits. Expression of ␣ 1I was decreased from e21 in the DA and from day 0 in the aorta.
The transcripts of all four ␣ 2␦ -subunits were detected in the DA and aorta (Fig. 1C) . Transcripts of all four ␤-subunits were detected in the DA and aorta (Fig. 1D) . Among them, ␤ 3 -subunit mRNA was highly expressed by semiquantitative RT-PCR during development in the DA and aorta. Expression of ␤ 3 -subunit mRNA was not changed during development. Expression of ␤ 1 -subunit mRNA was not detected in adult aorta. Fig. 2 . Relative abundance of L-type Ca 2ϩ channel ␣1-subunits in DA at e21. Uncut lane shows a single band corresponding to fragments obtained after RT-PCR; ␣1C, ␣1D, and ␣1S lanes show fragments obtained after restriction digest with enzymes. Digested fragments are indicated by arrows. Digested fragment was detected more in ␣1C-than in ␣1D-subunit. No digested fragment was detected in ␣1S-subunit. Values for ␣1C-and ␣1D-subunits were obtained from the value into which elements digested by each enzyme were divided by amount of uncut PCR product using densitometry. The ␣1C-subunit is the most abundant of the L-type Ca 2ϩ channel subunits. *P Ͻ 0.01. (29), we determined relative abundance of HVA Ca 2ϩ channel mRNA. The digested fragments were detected only in the ␣ 1C -and ␣ 1D -subunit lanes (Fig. 2) , which is consistent with the result from semiquantitative RT-PCR. The values of ␣ 1C -and ␣ 1D -subunits were obtained when the value into which elements digested by each enzyme was divided by the amount of uncut PCR product. The density of the digested fragment was significantly higher in the ␣ 1C -than in the ␣ 1D -subunit lane, indicating that the ␣ 1C -subunit is the most abundant transcript among L-type Ca 2ϩ channel subunits.
Protein expression of ␣ 1C -, ␣ 1D -, ␣ 1G -, and ␤ 3 -subunits in the DA. Protein expression of ␣ 1C -, ␣ 1D -, ␣ 1G -, and ␤ 3 -subunits was examined by immunoblotting analysis (Fig. 3) . Although the expression level of ␣ 1C -subunit mRNA was higher in the DA than in the fetal aorta, the expression level of ␣ 1C -subunit protein in the DA was comparable with that in the aorta at e21 and much less than that in the adult atrium and aorta. Protein expression of the ␣ 1D -subunit was similarly detected in the DA and aorta at e21, but not in the adult aorta. The level of ␣ 1G -subunit protein expression was high in the DA and aorta at e21 and undetectable in the adult aorta. We also detected ␤ 3 -subunit protein expression in the DA at e21.
In addition, we examined the localization of ␣ 1C -, ␣ 1D -, and ␣ 1G -subunit proteins in the DA at e21 by immunostaining with anti-␣ 1C , -␣ 1D , and -␣ 1G (Fig. 3B) . Strong immunoreaction of ␣ 1C -and ␣ 1G -subunits and moderate immunoreaction of the ␣ 1D -subunit were found in SMCs in the DA. Especially, the ␣ 1G -subunit was strongly expressed in the region of intimal thickening of the DA, which is clearly distinguished by Elastica stain. Fig. 3 . A: expression of ␣1C-, ␣1D-, ␣1G-, and ␤3-subunit protein in rat DA, aorta, and atrium by immunoblotting. Membrane proteins from rat tissues were separated by SDS-PAGE, together with prestained molecular weight markers, and subjected to immunoblot analysis with each subunit-selective antibody. Expression level of ␣1C-subunit protein was comparable in DA and aorta at e21 and much less in DA than in adult atrium. Expression of ␣1D-subunit was similarly detected in DA and aorta at e21. Expression of ␣1G-subunit protein was high in DA and aorta at e21 and undetectable in adult aorta. Expression of ␤3-subunit was high in DA at e21. B: DA at e21 immunostained with anti-␣1C, -␣1D, and -␣1G. Elastica stain identified the boundary of intimal cushion formation. High-magnification (ϫ4) image of the region of intimal cushion formation is shown at bottom. Strong immunoreaction of ␣1C-subunit and mild immunoreaction of ␣1D-subunit were ubiquitously found in DA. Strong ␣1G-subunit immunoreaction was especially found at the region of intimal thickening (IT) in DA. Scale bar, 100 m.
Effects of development and maternally administered vitamin
A on expression of VDCC ␣ 1 -subunit transcripts. Although the expression levels of ␣ 1C -subunit mRNA were not changed in the DA during development, a significant decrease in the expression level of ␣ 1C -subunit mRNA in the aorta resulted in a higher expression of ␣ 1C -subunit mRNA in the DA than in the aorta after e21 (Fig. 4A) . Maternally administered vitamin A significantly increased the expression levels of ␣ 1C -subunit mRNA at day 0 (P Ͻ 0.01; Fig. 4B) .
Expression of ␣ 1G -subunit mRNA was 25-120 times higher in perinatal vessels than in the adult aorta (Fig. 4C) . The expression was upregulated in the DA during development. The level of ␣ 1G -subunit mRNA was significantly higher in the DA than in the aorta at day 0. Maternally administered vitamin A significantly upregulated the expression of ␣ 1G -subunit mRNA at all developmental stages (P Ͻ 0.001; Fig. 4D) .
Effects of L-and T-type VDCCs on SMC proliferation in DA.
We used a specific L-type VDCC blocker (nitrendipine), a specific T-type VDCC blocker (kurtoxin), and an L-and T-type VDCC blocker (efonidipine) to investigate a role for VDCCs in SMC proliferation in the DA. Significant inhibition of [ 3 H]thymidine incorporation was observed in rat DA SMCs treated with 1 M nitrendipine, 3 M efonidipine, or 1 M kurtoxin compared with untreated SMCs (Fig. 5) . The inhibition was the strongest in SMCs treated with 3 M efonidipine, suggesting that the additive inhibitory effect of efonidipine on cell proliferation is due to the blockade of L-and T-type VDCCs in rat DA SMCs.
A novel spliced variant of the ␣ 1C -subunit was highly expressed in adult lung and fetal arteries. As demonstrated above, using RT-PCR with Ca v 1.2 (␣ 1C )-1 primers, we found a novel alternatively spliced isoform of the ␣ 1C -subunit in the DA and aorta ( Table 1 ). The PCR products were subcloned into a pCRII vector (Invitrogen) and sequenced. We reported the nucleotide sequence in the EMBL/GenBank nucleotide sequence databases (accession no. AY323810; Fig. 6A ). The spliced variant contained a 26-amino acid insertion into the I-II cytoplasmic linker that interacts with the ␤-subunit of ␣ 1C (Fig.  6B) . During the course of the present study, homologs of this variant have been reported in other species. Figure 6C shows Fig. 4 . A: developmental changes in expression of ␣1C-subunit mRNA. Expression level of ␣1C-subunit mRNA was higher in DA than in aorta (AO) at e21 and day 0. Expression level was not changed in DA during development but was decreased in aorta from e19 to e21. *P Ͻ 0.05. NS, not significant. B: effects of maternally administered vitamin A (MVA) on expression of ␣1C-subunit mRNA in DA. Levels of ␣1C-subunit mRNA were not changed in DA during development and were significantly increased with vitamin A only at day 0. *P Ͻ 0.05; **P Ͻ 0.01. C: developmental changes in expression of ␣1G-subunit mRNA. Transcripts for ␣1G-subunit were increased during development in DA. Abundance of ␣1G-subunit mRNA was significantly greater in DA than in aorta at day 0. **P Ͻ 0.01; ***P Ͻ 0.001. D: effects of maternally administered vitamin A on expression of ␣1G-subunit mRNA in DA. Expression of ␣1G-subunit mRNA was upregulated during development and significantly higher than with vitamin A at any developmental stage. **P Ͻ 0.01; ***P Ͻ 0.001. that amino acid sequence homology between the rat and other species (mouse, rabbit, and human) is very high (100%, 92%, and 88%, respectively).
We characterized the novel spliced isoform of rat ␣ 1C -subunit. Figure 7A shows the expression the spliced variant of ␣ 1C -subunit mRNA and protein by semiquantitative RT-PCR and immunoblotting analyses. The PCR product migrating 453 bp was the spliced variant of the ␣ 1C -subunit and the 378-bp band indicated the reported ␣ 1C -subunit. A relatively high intensity of the 453-bp band was detected in the DA and the aorta. Using the specific antibody against the spliced variant of the ␣ 1C -subunit, we also found a high level of expression of the variant protein in arteries, including the DA, and less expression in the adult heart.
By quantitative RT-PCR analyses, the spliced variant transcript was expressed most abundantly in the adult lung (data not shown), less in the fetal arteries, and least in the adult arteries. In other adult tissues, the expression level of ␣ 1C -subunit mRNA, including this spliced variant, was very low (data not shown). The ratio of the abundance of the spliced variant to the conventional ␣ 1C -isoform was measured by quantitative RT-PCR (see MATERIALS AND METHODS). The proportion of the spliced variant and nonspliced ␣ 1C -isoform was almost invariable (1-1.5) among the lung, DA, and aorta. Furthermore, we examined the developmental changes in the expression of the spliced variant of the ␣ 1C -subunit transcript in the DA and aorta (Fig. 7B) . The level of the spliced variant ␣ 1C -subunit mRNA peaked at e21 in the DA. After birth, the level of the spliced variant ␣ 1C -subunit mRNA was higher in the DA than in the aorta.
Localization of the spliced variant of the ␣ 1C -subunit in the DA at e21 was examined by immunostaining with anti-␣ 1C -subunit splicing variant (Fig. 7C) . Strong immunoreaction was found in the region of intimal thickening of the DA (Fig. 7C,  right) , whereas immunoreaction of the conventional ␣ 1C -isoform was ubiquitously expressed in the whole layers of the DA (Fig. 3B) . We examined whether the DA variant exerts any differences in the gating kinetics of the Ca 2ϩ channel. Activation and inactivation kinetics of I Ba were not significantly different between rbCII and the DA variant (Fig. 8A) . The expression level at the surface membrane, estimated as the density of I Ba , did not differ between the two groups, even though the individual cell showed a wide variety of I Ba density, as is often the case with a transient expression experiment (Fig. 8B) . The I-V relations of rbCII and the DA variant were almost superimposable (Fig. 8C) . V h-act of rbCII and the DA variant were Ϫ15.4 Ϯ 1.9 mV (n ϭ 9) and Ϫ14.5 Ϯ 1.2 mV (n ϭ 7), respectively (not statistically significant). The steady-state inactivation curves could be slightly shifted toward the depolarized direction in the DA variant, but V h-inact was not significantly different: Ϫ33.3 Ϯ 1.0 mV (n ϭ 9) and Ϫ31.5 Ϯ 1.7 mV (n ϭ 6), respectively.
DISCUSSION

Ca
2ϩ influx through VDCCs plays an important role in vascular myogenic reactivity and tone (4, 8, 26) . To our knowledge, the present study demonstrated the first complete characterization of the expression of VDCC subtype mRNAs in the DA. Tristani-Firouzi et al. (38) demonstrated that activation of L-type, but not T-type, VDCCs plays a major role in oxygen-sensitive contraction in the DA. Takizawa et al. (37) demonstrated that an L-type VDCC blocker, verapamil, inhibits spontaneous closure of the DA in newborn rats. Therefore, the abundant expression of ␣ 1C -subunit mRNA in the DA suggested that the ␣ 1C -subunit is mainly responsible for the influx of Ca 2ϩ that induces contraction of the DA after birth. We also found that all T-type VDCCs were expressed in the DA. The most dominant isoform among T-type VDCCs in the DA is the ␣ 1G -subunit, with an expression level 25-120 times higher in fetal vessels than in adult aorta, which is consistent with previous reports showing that T-type VDCCs are predominantly expressed in the early stages of differentiation of many embryonic and neonatal tissues (2, 9, 12, 21) . The expression of ␣ 1G -subunit mRNA was significantly upregulated by maternal administration of vitamin A. In the DA, ␣ 1G -subunit protein was highly localized in the region of intimal thicken- ing. Although the abundant expression of the ␣ 1G -subunit suggests that the ␣ 1G -subunit plays an important role in the DA, the physiological role of T-type VDCCs in smooth muscle contraction has been obscure. However, Ca 2ϩ influx through the ␣ 1H -subunit has been recently identified to be essential for normal relaxation of coronary arteries (4). Therefore, T-type VDCCs may play a similar role in the DA, rather than in oxygen-sensitive contraction (38) . Further investigation is necessary to test the possibility.
In addition to the regulation of vascular tone, L-and T-type VDCCs are also known to regulate differentiation (14, 17), proliferation (19, 36, 44) , migration (7, 31) , and gene expression (41) in vascular SMCs. In the present study, we found that L-and T-type Ca 2ϩ channel blockers significantly inhibited [ 3 H]thymidine incorporation in DA SMCs, suggesting that Land T-type VDCCs promote cell proliferation in the DA. Moreover, we found that BAY K 8644, an L-type VDCC activator, increased DA SMC migration in a dose-dependent manner (unpublished data). A previous study demonstrated that the blockade of T-type, but not L-type, VDCCs prevented neointima formation after vascular injury (32) , which shares a molecular mechanism of intimal thickening similar to that of the DA. Our present results, however, indicate that L-and T-type VDCCs are involved in intimal thickening in the DA in different ways.
Previous studies demonstrated that responses of the DA to oxygen and indomethacin, a prostaglandin H synthase inhibitor, are blunted at e19 and are apparent at e21 (24, 25) . In this study, the expression level of ␣ 1C -subunit mRNA at e19 was similar to that at e21 or day 0. Therefore, the expression level of the ␣ 1C -subunit was not considered the cause of the blunted response of the DA to oxygen and indomethacin at e19. One may argue that an oxygen-sensitive signal is activated at near term (e21) to increase the activity of VDCCs. In this sense, vitamin A and/or retinoic acid signaling is a candidate for the activator of oxygen sensitivity, because the retinoic acid response element is strongly expressed in the mouse DA (6), and maternally administered vitamin A accelerated development of the oxygen-sensing mechanism of the rat DA (42) . Previous studies have also demonstrated that retinoic acid upregulated ␣ 1C -subunit L-type Ca 2ϩ channel expression in vascular SMCs (13) and H 9 C 2 cardiac myoblast cell lines (22) . Although vitamin A upregulated the expression of ␣ 1C -subunit mRNA in the DA only at day 0, it would be of great interest that vitamin A and/or retinoic acid signal may enhance the activity of VDCCs in the DA.
We found a novel spliced variant of the ␣ 1C -subunit in the rat. The spliced variant contained a 25-amino acid insertion into the I-II cytoplasmic linker. The interaction between the cytoplasmic I-II linker of ␣ 1C -and ␤-subunits is known to modulate channel opening (16) . During the preparation of this manuscript, Liao et al. (18) reported the same spliced variant of the ␣ 1C -subunit. They demonstrated that the spliced variant of the ␣ 1C -subunit exhibited a hyperpolarized shift in voltagedependent activation and the I-V relation in HEK 293 cells. However, we did not find a difference in basic electrophysiological channel properties between the conventional and the spliced variant of ␣ 1C -subunits. Although we do not explain an exact reason for the conflicting results between two studies, the discrepancy may be due to the different conditions of the experiments: we used rat cDNA and the ␤ 1 -subunit, whereas Liao et al. used human cDNA and the ␤ 2 -subunit. Although we did not find a difference in basic channel properties between the conventional and the spliced variant of ␣ 1C -subunits, we found the distinct expression pattern of the spliced variant in the DA. The spliced variant was strongly expressed in neointimal thickening of the DA, where SMCs exhibit more proliferating and migrating characters (33, 34) . In addition, we found that expression of the spliced variant mRNA was significantly increased in the lung of monocrotaline-treated rats (unpublished data). These results suggest a distinct role for the spliced variant in adaptation to various physiological and/or pathological signals. D: steady-state inactivation curves of rbCII and the DA variant. Test pulse to 0 mV for 100 ms was applied after conditioning pulse for 5 s to the respective voltages ranging from Ϫ80 to 10 mV in 10-mV steps and for 25 ms at Ϫ70 mV. Values are means Ϯ SE.
In conclusion, multiple VDCC subunits were identified in the DA, and, in particular, ␣ 1C -and ␣ 1G -subunits were predominant in the DA. The expression of ␣ 1C -and ␣ 1G -subunit mRNAs was higher in the DA than in the aorta and was significantly upregulated by maternal administration of vitamin A. We found a novel spliced variant of the ␣ 1C -subunit gene that may play a specific role in Ca 2ϩ entry in the lung and fetal arteries. Our study could be an important first step in identification of the molecular basis of Ca 2ϩ channel function in the DA. On the basis of our results, further study would identify the physiological relevance between mRNA levels and Ca 2ϩ channel function in the DA.
